This inventor holds 2 USPTO granted patents. Top assignees: Baolong Pharmaceutical Co., Ltd., Shanghai Baolong Anqing Pharmaceutical Co., Ltd., Shanghai Baolong Pharmaceutical Co., Ltd.. Active years: 2026.
Company Filing History:
2 out of 2 
2 out of 2 
2 out of 2 Years Active: 2026
Title: Innovations of Inventor Xinmei Chen
Introduction
Xinmei Chen is a notable inventor based in Shanghai, China. She has made significant contributions to the field of pharmaceutics, particularly through her innovative research and development of new pharmaceutical compounds.
Latest Patents
One of her most recent patents is titled "Triptolide lignocerate, liposome thereof and preparation method therefor." This invention relates to the technical field of pharmaceutics and focuses on a triptolide lignocerate, a liposome derived from it, and the method of preparation. The chemical structural formula of the triptolide lignocerate is represented by formula (I). The triptolide lignocerate is obtained by esterification of triptolide C14-OH and lignoceric acid. This innovation improves the anti-tumor effectiveness and safety of the triptolide lignocerate liposome compared to prior art, laying the foundation for safer and more effective triptolide-related clinical preparations. Xinmei Chen holds 1 patent for this invention.
Career Highlights
Throughout her career, Xinmei Chen has worked with several prominent companies in the biopharmaceutical sector. Notable among these are Shanghai Wei Er Biopharmaceutical Technology Co., Ltd. and Shanghai Baolong Pharmaceutical Co., Ltd. Her work in these organizations has contributed to advancements in pharmaceutical technologies.
Collaborations
Xinmei Chen has collaborated with several professionals in her field, including her coworkers Xin Wu and Hang Chen. These collaborations have further enhanced her research and development efforts.
Conclusion
Xinmei Chen's innovative work in pharmaceutics, particularly her patent on triptolide lignocerate, showcases her commitment to advancing medical science. Her contributions are paving the way for safer and more effective clinical preparations.